Kieran English, based in San Francisco, is a member of the firm's Healthcare sector. She specializes in recruiting senior executives for diagnostic, pharmaceutical, biotechnology and medical-technology organizations. She has notable experience in identifying C-level talent for emerging molecular diagnostic and personalized medicine companies.
Recent Client Experience
Kieran’s clients range from early stage venture-backed healthcare companies to Fortune 500 companies. Some of her recent work includes recruiting the Senior Management Team for a Series A venture-backed molecular diagnostic company, Senior Commercial Leadership for a publicly held molecular diagnostic company and Executive Marketing talent for a global diversified Health and Well-being Company.
Kieran brings experience in biotechnology business development and strategic planning to her role at the firm. Before joining Russell Reynolds Associates, Kieran was Director of Business Development at Geron Corporation, where she was responsible for licensing deals. Previously, she was with Novartis/Chiron for six years; her last position there was Associate Director, Business Development Vaccines and Diagnostics. At Novartis/Chiron, Kieran focused on mergers and acquisitions activity in the oncology and infectious disease areas, licensing deals in the blood safety space and strategic opportunities in the molecular diagnostic industry. Earlier, Kieran spent a number of years as an analyst in a biotechnology focused hedge fund.
Additional Professional Activities
Kieran is a member of the Personalized Medicine Coalition and the Bay Area Council.
Kieran received her B.A. in English literature from Manhattan College and her M.B.A. in finance from Fordham University.